|
rdf:type |
|
|
lifeskim:mentions |
|
|
pubmed:issue |
47
|
|
pubmed:dateCreated |
2004-11-15
|
|
pubmed:abstractText |
Nuclear receptors and their coactivators are key regulators of numerous physiological functions. GRIP1 (glucocorticoid receptor-interacting protein) is a member of the steroid receptor coactivator family. Here, we show that GRIP1 is regulated by cAMP-dependent protein kinase (PKA) that induces its degradation through the ubiquitin-proteasome pathway. GRIP1 was down-regulated in transiently transfected COS-1 cells after treatment with 8-para-chlorophenylthio-cAMP or forskolin and 3-isobutyl-1-methylxanthine and in adrenocortical Y1 cells after incubation with adrenocorticotropic hormone. Pulse-chase experiments with transiently transfected COS-1 cells demonstrated that the half-life of GRIP1 was markedly reduced in cells overexpressing the PKA catalytic subunit, suggesting that activation of PKA increases the turnover of GRIP1 protein. The proteasome inhibitors MG132 and lactacystin abolished the PKA-mediated degradation of GRIP1. Using ts20 cells, a temperature-sensitive cell line that contains a thermolabile ubiquitin-activating E1 enzyme, it was confirmed that PKA-mediated degradation of GRIP1 is dependent upon the ubiquitin-proteasome pathway. Coimmunoprecipitation studies of COS-1 cells transfected with expression vectors encoding GRIP1 and ubiquitin using anti-GRIP1 and anti-ubiquitin antibodies showed that the ubiquitination of GRIP1 was increased by overexpression of PKA. Finally, we show that PKA regulates the intracellular distribution pattern of green fluorescent protein-GRIP1 and stimulates recruitment of GRIP1 to subnuclear foci that are colocalized with the proteasome. Taken together, these data demonstrate that GRIP1 is ubiquitinated and degraded through activation of the PKA pathway. This may represent a novel regulatory mechanism whereby hormones down-regulate a nuclear receptor coactivator.
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
IM
|
|
pubmed:chemical |
http://linkedlifedata.com/resource/pubmed/chemical/1-Methyl-3-isobutylxanthine,
http://linkedlifedata.com/resource/pubmed/chemical/8-((4-chlorophenyl)thio)cyclic-3',5'...,
http://linkedlifedata.com/resource/pubmed/chemical/Acetylcysteine,
http://linkedlifedata.com/resource/pubmed/chemical/Adaptor Proteins, Signal Transducing,
http://linkedlifedata.com/resource/pubmed/chemical/Cyclic AMP,
http://linkedlifedata.com/resource/pubmed/chemical/Cyclic AMP-Dependent Protein Kinases,
http://linkedlifedata.com/resource/pubmed/chemical/Enzyme Inhibitors,
http://linkedlifedata.com/resource/pubmed/chemical/Forskolin,
http://linkedlifedata.com/resource/pubmed/chemical/Leupeptins,
http://linkedlifedata.com/resource/pubmed/chemical/Luciferases,
http://linkedlifedata.com/resource/pubmed/chemical/Ncoa2 protein, mouse,
http://linkedlifedata.com/resource/pubmed/chemical/Nuclear Receptor Coactivator 2,
http://linkedlifedata.com/resource/pubmed/chemical/Protease Inhibitors,
http://linkedlifedata.com/resource/pubmed/chemical/Proteasome Endopeptidase Complex,
http://linkedlifedata.com/resource/pubmed/chemical/Thionucleotides,
http://linkedlifedata.com/resource/pubmed/chemical/Ubiquitin,
http://linkedlifedata.com/resource/pubmed/chemical/benzyloxycarbonylleucyl-leucyl-leuci...,
http://linkedlifedata.com/resource/pubmed/chemical/lactacystin
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
Nov
|
|
pubmed:issn |
0021-9258
|
|
pubmed:author |
|
|
pubmed:issnType |
Print
|
|
pubmed:day |
19
|
|
pubmed:volume |
279
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
49120-30
|
|
pubmed:dateRevised |
2008-11-21
|
|
pubmed:meshHeading |
pubmed-meshheading:15347661-1-Methyl-3-isobutylxanthine,
pubmed-meshheading:15347661-Acetylcysteine,
pubmed-meshheading:15347661-Adaptor Proteins, Signal Transducing,
pubmed-meshheading:15347661-Amino Acid Motifs,
pubmed-meshheading:15347661-Animals,
pubmed-meshheading:15347661-Blotting, Western,
pubmed-meshheading:15347661-COS Cells,
pubmed-meshheading:15347661-Cell Line,
pubmed-meshheading:15347661-Cell Line, Tumor,
pubmed-meshheading:15347661-Cell Nucleus,
pubmed-meshheading:15347661-Cyclic AMP,
pubmed-meshheading:15347661-Cyclic AMP-Dependent Protein Kinases,
pubmed-meshheading:15347661-Down-Regulation,
pubmed-meshheading:15347661-Enzyme Activation,
pubmed-meshheading:15347661-Enzyme Inhibitors,
pubmed-meshheading:15347661-Forskolin,
pubmed-meshheading:15347661-Genetic Vectors,
pubmed-meshheading:15347661-Immunoprecipitation,
pubmed-meshheading:15347661-Leupeptins,
pubmed-meshheading:15347661-Luciferases,
pubmed-meshheading:15347661-Mice,
pubmed-meshheading:15347661-Microscopy, Confocal,
pubmed-meshheading:15347661-Microscopy, Fluorescence,
pubmed-meshheading:15347661-Nuclear Receptor Coactivator 2,
pubmed-meshheading:15347661-Protease Inhibitors,
pubmed-meshheading:15347661-Proteasome Endopeptidase Complex,
pubmed-meshheading:15347661-Temperature,
pubmed-meshheading:15347661-Thionucleotides,
pubmed-meshheading:15347661-Time Factors,
pubmed-meshheading:15347661-Transcriptional Activation,
pubmed-meshheading:15347661-Transfection,
pubmed-meshheading:15347661-Ubiquitin
|
|
pubmed:year |
2004
|
|
pubmed:articleTitle |
cAMP-dependent protein kinase regulates ubiquitin-proteasome-mediated degradation and subcellular localization of the nuclear receptor coactivator GRIP1.
|
|
pubmed:affiliation |
Hormone Laboratory, Section of Endocrinology, Institute of Medicine, Division of Anatomy and Cell Biology, Department of Biomedicine, University of Bergen and Haukeland University Hospital, Bergen N-5021, Norway.
|
|
pubmed:publicationType |
Journal Article,
Research Support, Non-U.S. Gov't
|
